Gender Differences in the Risk of Ischemic Heart Disease According to Healthcare Utilization and Medication Adherence Among Newly Treated Korean Hypertensive Patients

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2021 Feb 12

PMID 33572632

Citations 2

Authors

Jiae Shin

Dongwoo Ham

Hee Young Paik

Sangah Shin

Hyojee Joung

Affiliations

Soon will be listed here.

Abstract

We aimed to investigate gender differences in ischemic heart disease (IHD) according to healthcare utilization and medication adherence among newly treated Korean hypertensive adults. The National Sample Cohort version 2.0 of the National Health Insurance Service was used for analysis. Newly treated hypertensive patients ≥ 20 years and without IHD in 2002 were selected from a population that underwent health examination during 2003-2006. Of those patients, 11,942 men and 11,193 women were analyzed and followed up for 10 years. We determined the association between IHD and healthcare utilization and medication adherence using the Cox proportional hazards model. Hypertensive women patients had a lower risk of IHD than men patients (hazard ratio [HR] = 0.93, 95% confidence interval [CI] 0.88-1.00). The IHD risk was increased in patients who visited healthcare providers > 12 times/person-year (HR = 2.97, 95% CI 2.79-3.17), paid high out-of-pocket expense/person-year (HR = 1.55, 95% CI 1.41-1.69), and had medication nonadherence (HR = 1.67, 95% CI 1.58-1.77). However, the risk was decreased in patients who used both urban and rural areas (HR 0.75, 95% CI 0.67-0.84) and mixed types of providers (HR = 0.93, CI 0.88-0.99). The risk of IHD was significantly different between men and women only in the visiting frequency to healthcare providers (men, HR = 3.21, 95% CI 2.93-3.52; women, HR = 2.78, 95% CI 2.53-3.04, for interaction = 0.0188). In summary, the risk of IHD was similar according to healthcare utilization and medication adherence between men and women, except visiting frequency to healthcare providers.

Citing Articles

Examining the factors associated with inpatients' perception of overtreatment in Korea: a cross-sectional study.

Jang J, Jung H BMC Health Serv Res. 2023; 23(1):633.

PMID: 37316854 PMC: 10268426. DOI: 10.1186/s12913-023-09563-9.

Mortality trend analysis of ischemic heart disease in China between 2010 and 2019: a joinpoint analysis.

Fu X, Wang J, Jiang S, Wu J, Mu Z, Tang Y BMC Public Health. 2023; 23(1):644.

PMID: 37016366 PMC: 10071740. DOI: 10.1186/s12889-023-15549-3.

References

Lee J, Lee J, Park S, Shin S, Kim K . Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2016; 46(2):e15. DOI: 10.1093/ije/dyv319. View

Kim H, Yoon S, Oh I, Lim J, Kim Y . Medication Adherence and the Occurrence of Complications in Patients with Newly Diagnosed Hypertension. Korean Circ J. 2016; 46(3):384-93. PMC: 4891603. DOI: 10.4070/kcj.2016.46.3.384. View

Li C, Engstrom G, Hedblad B, Janzon L . Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension. J Hypertens. 2006; 24(8):1523-9. DOI: 10.1097/01.hjh.0000239287.10013.e0. View

Gu Q, Burt V, Paulose-Ram R, Dillon C . Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004. Am J Hypertens. 2008; 21(7):789-98. DOI: 10.1038/ajh.2008.185. View

Sperber C, Samarasinghe S, Lomax G . An upper and lower bound of the Medication Possession Ratio. Patient Prefer Adherence. 2017; 11:1469-1478. PMC: 5590759. DOI: 10.2147/PPA.S136890. View

Shin S, Song H, Oh S, Choi K, Kim H, Jang S . Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res. 2013; 36(11):1000-5. DOI: 10.1038/hr.2013.85. View

. 2013 ESH/ESC Guidelines for the Management of Arterial Hypertension. Blood Press. 2013; 22(4):193-278. DOI: 10.3109/08037051.2013.812549. View

Kim S, Shin D, Yun J, Hwang Y, Park S, Ko Y . Medication Adherence and the Risk of Cardiovascular Mortality and Hospitalization Among Patients With Newly Prescribed Antihypertensive Medications. Hypertension. 2016; 67(3):506-12. DOI: 10.1161/HYPERTENSIONAHA.115.06731. View

Donahue R, Dorn J, Stranges S, Swanson M, Hovey K, Trevisan M . Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience. Nutr Metab Cardiovasc Dis. 2010; 21(7):504-11. PMC: 2888844. DOI: 10.1016/j.numecd.2009.11.012. View

10.

Rasmussen S, Prescott E, Sorensen T, Sogaard J . The total lifetime costs of smoking. Eur J Public Health. 2004; 14(1):95-100. DOI: 10.1093/eurpub/14.1.95. View

11.

Hansen R, Kim M, Song L, Tu W, Wu J, Murray M . Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009; 43(3):413-22. DOI: 10.1345/aph.1L496. View

12.

Wilkins K, Gee M, Campbell N . The difference in hypertension control between older men and women. Health Rep. 2013; 23(4):33-40. View

13.

Lee W, Shaw I . The impact of out-of-pocket payments on health care inequity: the case of national health insurance in South Korea. Int J Environ Res Public Health. 2014; 11(7):7304-18. PMC: 4113877. DOI: 10.3390/ijerph110707304. View

14.

Everett B, Zajacova A . Gender differences in hypertension and hypertension awareness among young adults. Biodemography Soc Biol. 2015; 61(1):1-17. PMC: 4896734. DOI: 10.1080/19485565.2014.929488. View

15.

Abuful A, Gidron Y, Henkin Y . Physicians' attitudes toward preventive therapy for coronary artery disease: is there a gender bias?. Clin Cardiol. 2005; 28(8):389-93. PMC: 6654010. DOI: 10.1002/clc.4960280809. View

16.

Doumas M, Papademetriou V, Faselis C, Kokkinos P . Gender differences in hypertension: myths and reality. Curr Hypertens Rep. 2013; 15(4):321-30. DOI: 10.1007/s11906-013-0359-y. View

17.

Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

18.

Perrino C, Ferdinandy P, Botker H, Brundel B, Collins P, Davidson S . Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2020; 117(2):367-385. PMC: 7820844. DOI: 10.1093/cvr/cvaa155. View

19.

Appelman Y, van Rijn B, Ten Haaf M, Boersma E, Peters S . Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015; 241(1):211-8. DOI: 10.1016/j.atherosclerosis.2015.01.027. View

20.

Ettehad D, Emdin C, Kiran A, Anderson S, Callender T, Emberson J . Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016; 387(10022):957-967. DOI: 10.1016/S0140-6736(15)01225-8. View